Please try another search
Eyenovia, Inc. is a pre-commercial ophthalmic technology company. The Company is developing the Optejet delivery system both for use in combination with its own drug-device therapeutics and for out-licensing for use in combination with therapeutics for additional indications. Its product candidates include MicroLine (for presbyopia), MicroPine (for progressive myopia) and Mydcombi (for mydriasis). MicroLine is its microdosed version of pilocarpine, a well-understood ophthalmic medication that can dose-dependently induce miosis, or a contraction of the pupil. MicroPine is a topical treatment for progressive myopia, a back-of-the-eye disease. MicroPine program involves the development of a micro-formulation of atropine ophthalmic solution for reduction of myopia progression in children. Mydcombi is a fixed combination micro-formulation product candidate for mydriasis (eye dilation). Its fixed combination product candidate has been developed to facilitate efficient pupil dilation.
Name | Age | Since | Title |
---|---|---|---|
Michael M. Rowe | 60 | 2018 | CEO & Director |
Tsontcho Ianchulev | 48 | 2014 | Co-Founder, President, Chief Medical Officer & Non-Executive Chairman |
Charles E. Mather | 62 | 2018 | Independent Director |
Ram Palanki | - | 2022 | Independent Director |
James C. Tsai | - | - | Member of Scientific Advisory Board |
Louis R. Pasquale | - | - | Member of Scientific Advisory Board |
Douglas Fredrick | - | - | Member of Scientific Advisory Board |
April Jasper | - | 2019 | Member of Scientific Advisory Board |
Shan Lin | - | - | Member of Scientific Advisory Board |
Robert N. Weinreb | - | - | Member of Scientific Advisory Board |
Rachel Jacobson | 48 | 2022 | Independent Director |
Stephen K. Benjamin | 52 | 2022 | Independent Director |
Pamela F. Gallin | - | - | Member of Scientific Advisory Board |
Mark Bullimore | - | 2019 | Member of Scientific Advisory Board |
Ellen R. Strahlman | 65 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review